FEASIBILITY PHASE OF THE MESOTHELIOMA AND RADICAL SURGERY (MARS) RANDOMISED CONTROLLED TRIAL COMPARING EXTRA-PLEURAL PNEUMONECTOMY (EPP) WITH NO EPP IN PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA

被引：0

作者：

Snee, Michael P. ^{[1
]}

Treasure, Tom ^{[2
]}

Bliss, Judith ^{[3
]}

Lang-Lazdunski, Loic ^{[4
]}

Waller, David ^{[5
]}

Tan, Carol ^{[6
]}

Entwisle, James ^{[7
]}

O'Brien, Mary ^{[8
,9
]}

Thomas, Gillian ^{[10
]}

Kilburn, Lucy ^{[3
]}

Senan, Suresh ^{[11
]}

Spicer, James ^{[4
]}

O'Byrne, Kenneth J. ^{[12
,13
]}

Landau, David ^{[4
]}

Coombes, Gillian ^{[3
]}

Edwards, John ^{[14
]}

Darlison, Liz ^{[5
]}

Peto, Julian ^{[15
]}

机构：

[1] St James Inst Oncol, Leeds, W Yorkshire, England

[2] UCL, Clin Operat Res Unit, London, England

[3] ICR, CTSU, Sutton, Surrey, England

[4] Guys & St Thomas NHS Fdn Trust, London, England

[5] Glenfield Gen Hosp, Leicester LE3 9QP, Leics, England

[6] St George Hosp, London, England

[7] Wellington Hosp, Wellington, New Zealand

[8] Royal Marsden NHS Fdn Trust, London, England

[9] Royal Marsden NHS Fdn Trust, Sutton, Surrey, England

[10] Leicester Royal Infirm, Leicester, Leics, England

[11] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands

[12] St James Hosp, Dublin, Ireland

[13] Trinity Coll Dublin, Dublin, Ireland

[14] No Gen Hosp, Sheffield S5 7AU, S Yorkshire, England

[15] London Sch Hyg & Trop Med, London WC1, England

来源：

JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期

关键词：

mesothelioma surgery radiotherapy chemotherapy;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S409 / S409

页数：1

共 50 条

[41] Phase II trial of oxaliplatin and gemcitabine in patients with malignant pleural or peritoneal mesothelioma
Hare, E.
Hesdorrfer, M. E.
Leinwand, J.
Batista, L.
Taub, R. N.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[42] Early specialist palliative care on quality of life for malignant pleural mesothelioma: a randomised controlled trial
Brims, Fraser
Gunatilake, Samal
Lawrie, Iain
Marshall, Laura
Fogg, Carole
Qi, Cathy
Creech, Lorraine
Holtom, Nicola
Killick, Stephanie
Yung, Bernard
Cooper, David
Stadon, Louise
Cook, Peter
Fuller, Elizabeth
Walther, Julie
Plunkett, Claire
Bates, Andrew
Mackinlay, Carolyn
Tandon, Anil
Maskell, Nicholas A.
Forbes, Karen
Rahman, Najib M.
Gerry, Stephen
Chauhan, Anoop J.
Bateman, Andrew
Dobson, Melissa
Hopgood, Richard
King, Samuel
Morgan, Angela
Morris, Stephen
Mortlock, Alice
Navani, Neal
Nowak, Anna
Peake, Michael
Roberts, Mark
Squibb, Lynne
Taylor, Paul
THORAX, 2019, 74 (04) : 354 - 361
[43] Phase I trial of neoadjuvant dasatinib in patients with resectable malignant pleural mesothelioma
Mehran, R.
Gil, J.
Rice, D.
Swisher, S.
Lee, J. J.
Lippman, S.
Pisters, K.
Blumenschein, G.
Hong, W. K.
Tsao, A. S.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[44] Phase I trial of neoadjuvant dasatinib in patients with resectable malignant pleural mesothelioma
Tsao, Anne S.
Gil, James
Rice, David
Swisher, Stephen
Lee, Jack J.
Lippman, Scott
Pisters, Katherine
Blumenschein, George
Hong, Waun K.
Mehran, Reza
JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S457 - S457
[45] A multi-institutional feasibility study of induction pemetremexed (Pem) plus cisplatin (Cis) followed by extrapleural pneumonectomy (EPP) and postoperative hemithoracic radiation (RT) for malignant pleural mesothelioma (MPM): Japan Mesothelioma Research Center (JMRC) 001001 trial
Tanaka, F.
Hasegawa, S.
Yamanaka, T.
Okada, M.
Soejima, T.
Kamikonya, N.
Yokoi, K.
Fukuoka, K.
Nakano, T.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[46] Comorbidity, postoperative morbidity and survival in patients undergoing radical surgery for malignant pleural mesothelioma
Infante, Maurizio
Morenghi, Emanuela
Bottoni, Edoardo
Zucali, Paolo
Rahal, Daoud
Morlacchi, Andrea
Ascolese, Anna Maria
De Rose, Fiorenza
Navarria, Pierina
Crepaldi, Alessandro
Testori, Alberto
Voulaz, Emanuele
Errico, Valentina
Perrino, Matteo
Scorsetti, Marta
Chiti, Arturo
Santoro, Armando
Alloisio, Marco
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2016, 50 (06) : 1077 - 1082
[47] Phase II feasibility trial of induction chemotherapy (ICT) followed by extrapleural pneumonectomy (EPP) and postoperative radiotherapy (PORT) for cT3N1M0 or less malignant pleural mesothelioma (MPM) (EORTC 08031)
Van Schil, P. E.
Baas, P.
Gaafar, R.
Maat, A. P.
van de Pol, M.
Hasan, B.
Klomp, H. M.
Abdelrahman, A. M.
Welch, J.
Van Meerbeeck, J.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[48] Extended pleurectomy decortication and chemotherapy versus chemotherapy alone for pleural mesothelioma (MARS 2): a phase 3 randomised controlled trial
Lim, Eric
Waller, David
Lau, Kelvin
Steele, Jeremy
Pope, Anthony
Ali, Clinton
Bilancia, Rocco
Keni, Manjusha
Popat, Sanjay
O'Brien, Mary
Tokaca, Nadza
Maskell, Nick
Stadon, Louise
Fennell, Dean
Nelson, Louise
Edwards, John
Tenconi, Sara
Socci, Laura
Rintoul, Robert C.
Wood, Kelly
Stone, Amanda
Muthukumar, Dakshinamoorthy
Ingle, Charlotte
Taylor, Paul
Cove-Smith, Laura
Califano, Raffaele
Summers, Yvonne
Tasigiannopoulos, Zacharias
Bille, Andrea
Shah, Riyaz
Fuller, Elizabeth
Macnair, Andrew
Shamash, Jonathan
Mansy, Talal
Milton, Richard
Koh, Pek
Ionescu, Andreea Alina
Treece, Sarah
Roy, Amy
Middleton, Gary
Kirk, Alan
Harris, Rosie A.
Ashton, Kate
Warnes, Barbara
Bridgeman, Emma
Joyce, Katherine
Mills, Nicola
Elliott, Daisy
Farrar, Nicola
Stokes, Elizabeth
LANCET RESPIRATORY MEDICINE, 2024, 12 (06): : 457 - 466
[49] Toxicity of EORTC 08031: phase 11 feasibility trial of induction chemotherapy (ICT) followed by extrapleural pneumonectomy (EPP) and postoperative radiotherapy (PORT) for malignant pleural mesothelioma (MPM) cT3N1M0 or less
Van Schil, Paul E.
Baas, Paul
Gaafar, Rabab
Maat, Alex P.
van de Pol, Marjan
Hasan, Baktiar
Klomp, Houke M.
Abdelrahman, Abdelrahman M.
Welch, John
Van Meerbeeck, Jan
JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S322 - S322
[50] A multicenter US trial of neoadjuvant pemetrexed plus cisplatin (PC) followed by extrapleural pneumonectomy (EPP) and hemithoracic radiation (RT) for stage I-III malignant pleural mesothelioma (MPM)
Krug, L. M.
Pass, H.
Rusch, V. W.
Kindler, H. L.
Sugarbaker, D.
Rosenzweig, K.
Friedberg, J. S.
Pisters, K.
Obasaju, C. K.
Vogelzang, N. J.
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)

← 1 2 3 4 5 →